Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective. Infusion Pharmacy includes infusion of antibiotic, antifungal, antiviral, pain management and nutritional drug through needle or catheter. Diseases such as cancer, diabetes, gastrointestinal disorder and pain related disorders are generally treated with infusion medication system. Infusion pharmacy can also be administered in home by providing doorstep services. 麻豆原创 infusion pharmacy management is more costly than hospital infusion pharmacy management because it requires more skilled nursing facilities. This report studies the Infusion Pharmacy Management market.
The global Infusion Pharmacy Management market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
In United States market, Infusion Pharmacy Management key players include BioScrip, BD, Cigna, Option Care, CVS Health, etc. The top five manufacturers hold a share about 70%. South is the largest market, with a share about 35%, followed by Midwest, with a share about 20 percent. In terms of product, Antimicrobial is the largest segment, with a share about 20%. And in terms of application, the largest application is 麻豆原创 Care, followed by Hospital & Clinic, Ambulatory Surgical Centers, etc.
This report is a detailed and comprehensive analysis for global Infusion Pharmacy Management market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Infusion Pharmacy Management market size and forecasts, in consumption value ($ Million), 2019-2030
Global Infusion Pharmacy Management market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Infusion Pharmacy Management market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Infusion Pharmacy Management market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infusion Pharmacy Management
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infusion Pharmacy Management market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioScrip, BD, Cigna, Option Care, CVS Health, McKesson, Mediware, OptumRx, Healix, CareCentrix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Infusion Pharmacy Management market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Infusion Pharmacy Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Antibiotics
Antimicrobial
Pain Management
Enteral Nutrition
Others
麻豆原创 segment by Application
Hospital & Clinic
Ambulatory Surgical Centers
麻豆原创 Care
麻豆原创 segment by players, this report covers
BioScrip
BD
Cigna
Option Care
CVS Health
McKesson
Mediware
OptumRx
Healix
CareCentrix
MedicoRx
Ivenix
ARJ Infusion Services
Brightree
Accredo Health
MHA
ContinuumRx
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infusion Pharmacy Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infusion Pharmacy Management, with revenue, gross margin, and global market share of Infusion Pharmacy Management from 2019 to 2024.
Chapter 3, the Infusion Pharmacy Management competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infusion Pharmacy Management market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infusion Pharmacy Management.
Chapter 13, to describe Infusion Pharmacy Management research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Infusion Pharmacy Management by Type
1.3.1 Overview: Global Infusion Pharmacy Management 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infusion Pharmacy Management Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Antibiotics
1.3.4 Antimicrobial
1.3.5 Pain Management
1.3.6 Enteral Nutrition
1.3.7 Others
1.4 Global Infusion Pharmacy Management 麻豆原创 by Application
1.4.1 Overview: Global Infusion Pharmacy Management 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital & Clinic
1.4.3 Ambulatory Surgical Centers
1.4.4 麻豆原创 Care
1.5 Global Infusion Pharmacy Management 麻豆原创 Size & Forecast
1.6 Global Infusion Pharmacy Management 麻豆原创 Size and Forecast by Region
1.6.1 Global Infusion Pharmacy Management 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infusion Pharmacy Management 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Infusion Pharmacy Management 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Infusion Pharmacy Management 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infusion Pharmacy Management 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Infusion Pharmacy Management 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Infusion Pharmacy Management 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 BioScrip
2.1.1 BioScrip Details
2.1.2 BioScrip Major Business
2.1.3 BioScrip Infusion Pharmacy Management Product and Solutions
2.1.4 BioScrip Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 BioScrip Recent Developments and Future Plans
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Infusion Pharmacy Management Product and Solutions
2.2.4 BD Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 BD Recent Developments and Future Plans
2.3 Cigna
2.3.1 Cigna Details
2.3.2 Cigna Major Business
2.3.3 Cigna Infusion Pharmacy Management Product and Solutions
2.3.4 Cigna Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Cigna Recent Developments and Future Plans
2.4 Option Care
2.4.1 Option Care Details
2.4.2 Option Care Major Business
2.4.3 Option Care Infusion Pharmacy Management Product and Solutions
2.4.4 Option Care Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Option Care Recent Developments and Future Plans
2.5 CVS Health
2.5.1 CVS Health Details
2.5.2 CVS Health Major Business
2.5.3 CVS Health Infusion Pharmacy Management Product and Solutions
2.5.4 CVS Health Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 CVS Health Recent Developments and Future Plans
2.6 McKesson
2.6.1 McKesson Details
2.6.2 McKesson Major Business
2.6.3 McKesson Infusion Pharmacy Management Product and Solutions
2.6.4 McKesson Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 McKesson Recent Developments and Future Plans
2.7 Mediware
2.7.1 Mediware Details
2.7.2 Mediware Major Business
2.7.3 Mediware Infusion Pharmacy Management Product and Solutions
2.7.4 Mediware Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Mediware Recent Developments and Future Plans
2.8 OptumRx
2.8.1 OptumRx Details
2.8.2 OptumRx Major Business
2.8.3 OptumRx Infusion Pharmacy Management Product and Solutions
2.8.4 OptumRx Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 OptumRx Recent Developments and Future Plans
2.9 Healix
2.9.1 Healix Details
2.9.2 Healix Major Business
2.9.3 Healix Infusion Pharmacy Management Product and Solutions
2.9.4 Healix Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Healix Recent Developments and Future Plans
2.10 CareCentrix
2.10.1 CareCentrix Details
2.10.2 CareCentrix Major Business
2.10.3 CareCentrix Infusion Pharmacy Management Product and Solutions
2.10.4 CareCentrix Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 CareCentrix Recent Developments and Future Plans
2.11 MedicoRx
2.11.1 MedicoRx Details
2.11.2 MedicoRx Major Business
2.11.3 MedicoRx Infusion Pharmacy Management Product and Solutions
2.11.4 MedicoRx Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 MedicoRx Recent Developments and Future Plans
2.12 Ivenix
2.12.1 Ivenix Details
2.12.2 Ivenix Major Business
2.12.3 Ivenix Infusion Pharmacy Management Product and Solutions
2.12.4 Ivenix Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Ivenix Recent Developments and Future Plans
2.13 ARJ Infusion Services
2.13.1 ARJ Infusion Services Details
2.13.2 ARJ Infusion Services Major Business
2.13.3 ARJ Infusion Services Infusion Pharmacy Management Product and Solutions
2.13.4 ARJ Infusion Services Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 ARJ Infusion Services Recent Developments and Future Plans
2.14 Brightree
2.14.1 Brightree Details
2.14.2 Brightree Major Business
2.14.3 Brightree Infusion Pharmacy Management Product and Solutions
2.14.4 Brightree Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Brightree Recent Developments and Future Plans
2.15 Accredo Health
2.15.1 Accredo Health Details
2.15.2 Accredo Health Major Business
2.15.3 Accredo Health Infusion Pharmacy Management Product and Solutions
2.15.4 Accredo Health Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Accredo Health Recent Developments and Future Plans
2.16 MHA
2.16.1 MHA Details
2.16.2 MHA Major Business
2.16.3 MHA Infusion Pharmacy Management Product and Solutions
2.16.4 MHA Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 MHA Recent Developments and Future Plans
2.17 ContinuumRx
2.17.1 ContinuumRx Details
2.17.2 ContinuumRx Major Business
2.17.3 ContinuumRx Infusion Pharmacy Management Product and Solutions
2.17.4 ContinuumRx Infusion Pharmacy Management Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 ContinuumRx Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Infusion Pharmacy Management Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Infusion Pharmacy Management by Company Revenue
3.2.2 Top 3 Infusion Pharmacy Management Players 麻豆原创 Share in 2023
3.2.3 Top 6 Infusion Pharmacy Management Players 麻豆原创 Share in 2023
3.3 Infusion Pharmacy Management 麻豆原创: Overall Company Footprint Analysis
3.3.1 Infusion Pharmacy Management 麻豆原创: Region Footprint
3.3.2 Infusion Pharmacy Management 麻豆原创: Company Product Type Footprint
3.3.3 Infusion Pharmacy Management 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Infusion Pharmacy Management Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Infusion Pharmacy Management 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Infusion Pharmacy Management Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Infusion Pharmacy Management 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Infusion Pharmacy Management Consumption Value by Type (2019-2030)
6.2 North America Infusion Pharmacy Management 麻豆原创 Size by Application (2019-2030)
6.3 North America Infusion Pharmacy Management 麻豆原创 Size by Country
6.3.1 North America Infusion Pharmacy Management Consumption Value by Country (2019-2030)
6.3.2 United States Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Infusion Pharmacy Management Consumption Value by Type (2019-2030)
7.2 Europe Infusion Pharmacy Management Consumption Value by Application (2019-2030)
7.3 Europe Infusion Pharmacy Management 麻豆原创 Size by Country
7.3.1 Europe Infusion Pharmacy Management Consumption Value by Country (2019-2030)
7.3.2 Germany Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Infusion Pharmacy Management Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infusion Pharmacy Management Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infusion Pharmacy Management 麻豆原创 Size by Region
8.3.1 Asia-Pacific Infusion Pharmacy Management Consumption Value by Region (2019-2030)
8.3.2 China Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Infusion Pharmacy Management Consumption Value by Type (2019-2030)
9.2 South America Infusion Pharmacy Management Consumption Value by Application (2019-2030)
9.3 South America Infusion Pharmacy Management 麻豆原创 Size by Country
9.3.1 South America Infusion Pharmacy Management Consumption Value by Country (2019-2030)
9.3.2 Brazil Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Infusion Pharmacy Management Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infusion Pharmacy Management Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infusion Pharmacy Management 麻豆原创 Size by Country
10.3.1 Middle East & Africa Infusion Pharmacy Management Consumption Value by Country (2019-2030)
10.3.2 Turkey Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Infusion Pharmacy Management 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Infusion Pharmacy Management 麻豆原创 Drivers
11.2 Infusion Pharmacy Management 麻豆原创 Restraints
11.3 Infusion Pharmacy Management Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Infusion Pharmacy Management Industry Chain
12.2 Infusion Pharmacy Management Upstream Analysis
12.3 Infusion Pharmacy Management Midstream Analysis
12.4 Infusion Pharmacy Management Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
BioScrip
BD
Cigna
Option Care
CVS Health
McKesson
Mediware
OptumRx
Healix
CareCentrix
MedicoRx
Ivenix
ARJ Infusion Services
Brightree
Accredo Health
MHA
ContinuumRx
听
听
*If Applicable.